MARKET

SGEN

SGEN

Seagen Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

139.64
-2.99
-2.10%
After Hours: 139.64 0 0.00% 16:10 05/20 EDT
OPEN
144.20
PREV CLOSE
142.63
HIGH
144.46
LOW
136.11
VOLUME
1.69M
TURNOVER
0
52 WEEK HIGH
192.79
52 WEEK LOW
105.43
MARKET CAP
25.70B
P/E (TTM)
-36.9956
1D
5D
1M
3M
1Y
5Y
US Stocks Begin Week Mostly Lower Amid Empire State Manufacturing Weakness
MT Newswires · 6d ago
US Stocks Begin Week Mostly Lower as First Manufacturing Data for May Turns Negative
MT Newswires · 6d ago
Seagen says CEO has resigned
Shares of Seagen Inc. were up 2.4% in trading on Monday after the company said its president and CEO Clay Siegall has resigned. Seagen had announced last week that Siegall would take a leave of absence after he was allegedly involved in a domestic violence...
marketwatch.com · 6d ago
Insider Sell: Seagen
MT Newswires · 6d ago
Seagen's President, CEO Clay Siegall Resigns Amid Investigation
MT Newswires · 6d ago
Recent 10.0% pullback isn't enough to hurt long-term Seagen (NASDAQ:SGEN) shareholders, they're still up 90% over 5 years
Seagen Inc. ( NASDAQ:SGEN ) shareholders might be concerned after seeing the share price drop 17% in the last month. On...
Simply Wall St. · 05/12 14:57
77 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 05/10 16:01
Seagen CEO goes on leave amid domestic violence allegations
Seagen Chief Medical Officer Roger Dansey is taking over as interim CEO for the company, which is conducting an investigation with an independent law firm.
American City Business Journals · 05/09 20:33
More
No Data
Learn about the latest financial forecast of SGEN. Analyze the recent business situations of Seagen Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 21 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

23.81%Strong Buy
33.33%Buy
42.86%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SGEN stock price target is 159.88 with a high estimate of 191.00 and a low estimate of 120.00.
High191.00
Average159.88
Low120.00
Current 139.64
EPS
Actual
Estimate
-1.29-0.97-0.64-0.32
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 688
Institutional Holdings: 179.38M
% Owned: 97.45%
Shares Outstanding: 184.08M
TypeInstitutionsShares
Increased
179
10.13M
New
47
1.97M
Decreased
181
9.61M
Sold Out
62
1.65M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.64%
Pharmaceuticals & Medical Research
+1.63%
Key Executives
Non-Executive Chairman/Independent Director
Felix Baker
Chief Executive Officer
Roger Dansey
Chief Financial Officer
Todd Simpson
Executive Vice President
Lee Heeson
Executive Vice President
Chip Romp
Chief Technology Officer
Vaughn Himes
Secretary
Jean Liu
Independent Director
David Gryska
Independent Director
Ted Love
Independent Director
John Orwin
Independent Director
Alpna Seth
Independent Director
Nancy Simonian
Independent Director
Daniel Welch
No Data
No Data
About SGEN
Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in the development and sale of pharmaceutical products on its own, behalf or in collaboration with others. The Company is commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, and TUKYSA, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. The Company also develops a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs. Its programs, including ADCETRIS and PADCEV, are based on its antibody-drug conjugate (ADC), technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The Company's approved medicines include ADCETRIS, PADCEV and TUKYSA.

Webull offers kinds of Seagen Inc stock information, including NASDAQ:SGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SGEN stock methods without spending real money on the virtual paper trading platform.